Kathryn Schnippel Bistline
Kathryn Schnippel Bistline
Substance Abuse and Mental Health Services Administration
Verifisert e-postadresse på samhsa.hhs.gov
Sitert av
Sitert av
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ...
The Lancet 392 (10150), 821-834, 2018
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
K Schnippel, N Ndjeka, G Maartens, G Meintjes, I Master, N Ismail, ...
The Lancet Respiratory Medicine 6 (9), 699-706, 2018
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
G Meyer-Rath, K Schnippel, L Long, W MacLeod, I Sanne, W Stevens, ...
PloS one 7 (5), e36966, 2012
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
N Ndjeka, F Conradie, K Schnippel, J Hughes, N Bantubani, H Ferreira, ...
The International Journal of Tuberculosis and Lung Disease 19 (8), 979-985, 2015
Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa
B Larson, K Schnippel, B Ndibongo, T Xulu, A Brennan, L Long, MP Fox, ...
Journal of acquired immune deficiency syndromes (1999) 61 (2), e13, 2012
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ...
European Respiratory Journal 52 (6), 2018
Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa
K Schnippel, G Meyer‐Rath, L Long, W MacLeod, I Sanne, WS Stevens, ...
Tropical Medicine & International Health 17 (9), 1142-1151, 2012
How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima™ analyzer in South Africa
B Larson, K Schnippel, B Ndibongo, L Long, MP Fox, S Rosen
PloS one 7 (4), e35444, 2012
Costs of inpatient treatment for multi‐drug‐resistant tuberculosis in S outh A frica
K Schnippel, S Rosen, K Shearer, N Martinson, L Long, I Sanne, ...
Tropical Medicine & International Health 18 (1), 109-116, 2013
Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa
A Van Rie, L Page-Shipp, CF Hanrahan, K Schnippel, H Dansey, ...
The International journal of tuberculosis and lung disease 17 (3), 368-372, 2013
Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis
K Schnippel, C Firnhaber, R Berhanu, L Page-Shipp, E Sinanovic
Journal of Antimicrobial Chemotherapy 72 (7), 1871-1879, 2017
Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort …
K Schnippel, K Shearer, D Evans, R Berhanu, N Ndjeka
International Journal of Infectious Diseases 39, 89-94, 2015
Diagnosing Xpert MTB/RIF-negative TB: Impact and cost of alternative algorithms for South Africa
K Schnippel, G Meyer-Rath, L Long, WS Stevens, I Sanne, S Rosen
South African Medical Journal 103 (2), 101-106, 2013
Same-day CD4 testing to improve uptake of HIV care and treatment in South Africa: point-of-care is not enough
BA Larson, K Schnippel, A Brennan, L Long, T Xulu, T Maotoe, S Rosen, ...
AIDS research and treatment 2013, 2013
Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
K Schnippel, RH Berhanu, A Black, C Firnhaber, N Maitisa, D Evans, ...
BMC Infectious Diseases 16 (1), 1-10, 2016
Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis
K Schnippel, C Mongwenyana, LC Long, BA Larson
BMC infectious diseases 15 (1), 1-6, 2015
Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa
N Cassim, LM Coetzee, K Schnippel, DK Glencross
PloS one 9 (12), e115420, 2014
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
D Evans, T Sineke, K Schnippel, R Berhanu, C Govathson, A Black, ...
BMC health services research 18, 1-12, 2018
The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
T Sineke, D Evans, K Schnippel, H van Aswegen, R Berhanu, N Musakwa, ...
Health and quality of life outcomes 17 (1), 1-15, 2019
Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa
K Schnippel, C Firnhaber, N Ndjeka, F Conradie, L Page-Shipp, ...
The International Journal of Tuberculosis and Lung Disease 21 (10), 1106-1111, 2017
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20